Research Triangle Park, North Carolina, April 25, 2017. Marken has launched a 24 hour, 7 day a week call center for patients enrolled in clinical trials. The call center, known as Marken’s ‘Patient Interaction Center (PIC)’, is based in Philadelphia (USA) and is dedicated to the logistics needs of patients who participate in home-based clinical trials.
Marken leads the industry in clinical trial drug delivery and sample collection to and from patient’s homes. These so-called ‘direct to patient’ services are rapidly growing as an important component of clinical trials. Patients who have trouble travelling to and from their clinical sites can now receive treatment at home and have their samples collected from their home. Marken offers these services and can partner with home nursing care companies to provide a full service solution. Marken’s new call center further enhances their home service by allowing patients to contact a specialist to schedule a pick-up or delivery. The call center operates around the clock, 24/7/365. PIC call specialists are trained for each clinical protocol and provide instructions to Marken’s operators and drivers on a case by case basis. Marken works with its clients, either Clinical Research Organizations (CROs) or pharmaceutical companies, to ensure strict compliance with each clinical protocol and the strict regulatory compliance requirements which apply.
Wes Wheeler, Chief Executive Officer for Marken said, “We are working hard to enhance our portfolio of unique services to the clinical trial industry. We have embraced the industry’s focus on patient-centric clinical trials and now consider ourselves a leader in direct to patient services. The new call center, which we call the ‘Patient Interactive Center’ is another example of the investments we are making to improve the clinical trial process for our clients and their patients. Marken pioneered direct to patient services 5 years ago and since then we have gained the trust of our clients because of our commitment to the patient, their confidentiality, and compliance with local data protection laws”.
